Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
批准号:
16390413
负责人:
ARAKI Norie
金额:
$8.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
神经纤维瘤病1型(NF 1)和2型(NF 2)是一种常染色体显性遗传疾病,与双侧前庭神经鞘瘤、脑膜瘤和胶质瘤等颅内肿瘤的发生密切相关。为了阐明NF 1和NF 2基因产物的生物学功能,我们利用siRNA技术和蛋白质组学策略分析了NF 1和NF 2基因产物的细胞信号转导。1)NF 1; NF 1 siRNA诱导特征性形态学变化,如过度的肌动蛋白应力纤维形成,coffin磷酸化水平升高,其通过解聚和切断肌动蛋白丝来调节肌动蛋白细胞骨架重组,并且通过Rho-ROCK-LIMK 2途径的激活来促进,这需要Ras激活。用定量差异蛋白质组学策略(iTRAQ)鉴定了53个与神经纤维蛋白相关的蛋白质。这些蛋白质包括钙调素反应介体蛋白-2(CRMP-2)、钙调素(CaM)、14-3-3蛋白、Micr ...更多信息 在PC 12细胞中,CRMP 2和微管蛋白与神经纤维蛋白的结合通过其磷酸化方式调节。NF 1 SiRNA显著抑制PC 12细胞突起的生长,其作用机制与通过GSK-3b、Rho激酶等调节CRMP-2磷酸化有关。神经纤维蛋白在调节细胞骨架重组的机制中具有重要作用,其影响细胞运动、粘附和分化。2)NF 2;鉴定了28种merlin的细胞结合蛋白,主要集中在DNA修复酶,如聚ADP-核糖聚合酶,DNA-PK亚基Ku-抗原85和70。Merlin蛋白的N端(19-339)区域是它们相互作用的关键。merlin和PARP的亚细胞共定位主要在它们的核区域,并具有merlin的核输出信号(内斯)依赖性。这种核积累随着细胞DNA损伤而增加,而MEF(PARP-/-)不能在其核区域积累merlin。这些结果表明,merlin是一个细胞质-核穿梭蛋白指导其NES依赖的运输途径与PARP。NF蛋白通过其细胞相关蛋白进行功能调节是必不可少的,NF基因异常引起的NF蛋白功能异常调节可能参与NF相关的发病机制。少
英文摘要
The neurofibromatosis type 1 (NF1) and type 2 (NF2) are autosomal dominantly inherited disorders, and strongly associated with development of intracranial tumors including bilateral vestibular schwannomas, meningiomas and gliomas. To elucidate the biological function of NF1 and NF2 gene products, and, we analyzed their cellular signal transductions by using siRNA techniques and proteomic strategies. 1)NF1 ; NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated phosphorylation levels of coffin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments, and that was promoted by the activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation. Fifty three proteins associating to neurofibromin were identified with the quantitative differential proteomic strategy (iTRAQ). These proteins contain collapsin response mediator protein-2 (CRMP-2), calmodulin (CaM), 14-3-3 proteins, Micr … More otubule-associated proteins, coffilin etc. In PC12 cells, the associations of CRMP2 and tubulin to neurofibromin were regulated by their phosphorylation manners. NF1 SiRNA significantly inhibited the neurite extension of PC12 cells, which was correlated with the regulation of CRMP-2 phosphorylations via GSK-3b, Rho-kinase, and other kinases. Neurofibromin has significant roles in the machinery regulating cellular cytoskeletal reorganization, which affects cell motility, adhesion, and differentiations. 2)NF2 ; 28 cellular binding proteins of merlin were identified, and focused on DNA repair enzymes such as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70. The N-terminal (19-339) region of merlin is essential for their interaction. Subcellular co-localizations of merlin and PARP were observed mainly in their nuclear region with a nuclear export signal (NES) dependent manner of merlin. This nuclear accumulation increased with cellular DNA damages, whereas MEF (PARP-/-) could not accumulate merlin in their nuclear region. These results suggest that merlin is a cytoplasmic-nuclear shuttling protein directed by its NES-dependent transport pathway being associated with PARP. Functional regulations of NF proteins via their cellular associating proteins are essential, and their abnormal regulations caused by NF gene aberrations may be implicated in NF-related pathogenesis. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1369/jhc.5a6871.2006
发表时间:
2006-07-01
期刊:
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
影响因子:
3.2
作者:
[Komohara, Yoshihiro, Hirahara, Junko, Takeya, Motohiro]
通讯作者:
Takeya, Motohiro
Methods for protein purification from biological samples.
从生物样品中纯化蛋白质的方法。
DOI:
--
发表时间:
2004
期刊:
Tanpakushitsu Kakusan Koso. 49(11)
影响因子:
--
作者:
[Kurihara N, Reddy SV, Araki N, Ishizuka S, Ozono K, Cornish J, Cundy T, Singer FR, Roadman GD., Araki N^*.]
通讯作者:
Araki N^*.
「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析
使用“体外标记法”在线LC-MS方法进行表达谱分析
DOI:
--
发表时间:
2004
期刊:
決定版!プロテオーム解析マニュアル
影响因子:
--
作者:
[Araki, N., 荒木令江]
通讯作者:
荒木令江
プロテオミクスによる疾患研究と臨床診断に向かう戦略
使用蛋白质组学进行疾病研究和临床诊断的策略
DOI:
--
发表时间:
2004
期刊:
疾患プロテオミクスの最前線 2
影响因子:
--
作者:
[Araki, N., 荒木令江, 荒木令江, 荒木令江]
通讯作者:
荒木令江
二次元電気泳動に関すること
关于二维电泳
DOI:
--
发表时间:
2005
期刊:
タンパク質研究なるほどQ&A
影响因子:
--
作者:
[Akiba S., et. al., 荒木令江]
通讯作者:
荒木令江
共 18 条
Analysis of molecular network on maintenance and differentiation of glioma stem cells
-
批准号:25640068
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:ARAKI Norie
-
依托单位:
System development for microquantitative molecular analyses ofglioma stem cells
-
批准号:23659693
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:ARAKI Norie
-
依托单位:
Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
-
批准号:22390281
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
-
批准号:19390382
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products
-
批准号:14571319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
-
批准号:12671369
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
-
批准号:10671308
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1998
-
负责人:ARAKI Norie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NF1突变驱动破骨细胞激活和增殖的机制研究及其对先天性胫骨假关节的治疗意义
-
批准号:2026JJ82341
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周天生
-
依托单位:
芦沃美替尼(治疗2岁及2岁以上伴有症状、无法手术的丛状神经纤维瘤(PN)的1型神经纤维瘤病(NF1)儿童及青少年患者)应用示范项目
-
批准号:25SF1901100
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡晓洁
-
依托单位:
剪接因子 SF3B1 R625 位突变通过高强度异常剪接 NF1/RASA1/RASA2 偏好性
驱动黑色素瘤发生的机制
-
批准号:24ZR1442800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:姜芮昕
-
依托单位:
NF1 通过调节巨噬细胞极化介导局部微环境在先天
性胫骨假关节发病过程中的作用机制研究
-
批准号:2024JJ5217
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:朱光辉
-
依托单位:
NF1基因突变增加胶质母细胞瘤对PARP1抑制剂化疗敏感性的机制研究
-
批准号:82360566
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:潘亚文
-
依托单位:
核糖体蛋白L3在神经纤维瘤中靶向NF1的作用及机制研究
-
批准号:62003107
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王元丽
-
依托单位:
NF1基因突变通过抑制血管周细胞募集提高胶质母细胞瘤化疗效果的机制研究
-
批准号:81960541
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:袁国强
-
依托单位:
选择性剪切调控Nf1缺失小鼠成体神经干细胞分化潜能的机制研究
-
批准号:31871376
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:汪源
-
依托单位:
miR-5000-3p双靶向调控Myc和NF1在结肠癌SP细胞多药耐药性中的作用及其分子标志物的价值
-
批准号:81772268
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:夏忠胜
-
依托单位:
NF1介导HER2阳性胃癌对曲妥珠单抗耐药的分子机制及其靶向干预研究:走进胃癌“精准治疗”时代
-
批准号:81602070
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:王德深
-
依托单位: